Research area · week to 3 Oct 2026

Coagulation, Bradykinin, Polyphosphates, and Angioedema

Moving in New England Journal of Medicine, Blood, BMJ, Nature Reviews Cancer.

Moved this week: 0

Rebuilt 3 October 2026 at 2:42 pm AEST

Moved this week

Everything that moved →

Nothing in this area has moved yet this week.

Latest in Coagulation, Bradykinin, Polyphosphates, and Angioedema

Newest first · last 60 days

Expanding the reach of menin inhibitors.
Nature Reviews Cancer · 1 Oct 2026 · Journal Article
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42686827
Open in JClub
UK regulator plans to withdraw controversial vasculitis drug Tavneos over unreliable data.
BMJ · 2 Sept 2026 · Journal Article
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42686357
Open in JClub
Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event.
New England Journal of Medicine · 29 Aug 2026 · Journal Article
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42670965
Open in JClub
Emerging Era for Polymyalgia Rheumatica and GCA - Interleukin-17A Targeting.
New England Journal of Medicine · 13 Aug 2026 · Editorial
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42234538
Open in JClub
Prior anticoagulation experience and bleeding risk with the factor XI inhibitor abelacimab in the AZALEA-TIMI 71 study.
Blood · 6 Aug 2026 · Randomized Controlled Trial
Prior oral anticoagulation experience influences bleeding risk, but abelacimab reduces bleeding consistently across atrial fibrillation patients, with greater benefit in OAC-naïve individuals.
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42213637
Open in JClub

Follow this area in the app

Journals this month

All journals →

Moving areas, week to 3 Oct 2026

All research areas →

Read